MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-17-2025
Zynex Total Liabilities 2011-2026 | ZYXI
Annual Total Liabilities Zynex
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86.4 M | 90.8 M | 50.1 M | 59.3 M | 15.3 M | 8.62 M | 6.89 M | 4.03 M | 7.89 M | 7.77 M | 8.38 M | 12.4 M | 13.9 M | 11.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90.8 M | 4.03 M | 27.4 M |
Quarterly Total Liabilities Zynex
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86.7 M | 84.7 M | 85 M | 86.4 M | 90.3 M | 89.1 M | 93.1 M | 90.8 M | 92.8 M | 90.3 M | 46.6 M | 50.1 M | 50.2 M | - | 56.2 M | 59.3 M | 27.3 M | 26.4 M | 14.1 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 8.62 M | 8.62 M | 8.62 M | 8.62 M | 9.96 M | 9.96 M | 9.96 M | 9.96 M | 4.03 M | 4.03 M | 4.03 M | 4.03 M | 7.89 M | 7.89 M | 7.89 M | 7.89 M | 7.77 M | 7.77 M | 7.77 M | 7.77 M | 8.38 M | 8.38 M | 8.38 M | 8.38 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 11.6 M | 11.6 M | 11.6 M | 11.6 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 93.1 M | 4.03 M | 27.9 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
82.4 M | - | - | $ 3.31 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 11.16 | -0.09 % | $ 316 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 8.27 | 0.55 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.33 | 0.23 % | $ 162 M |  France |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
83.7 M | $ 5.86 | 1.03 % | $ 70.1 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.02 M | $ 2.31 | 6.94 % | $ 50.9 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.47 | -0.53 % | $ 29.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 18.4 | 0.93 % | $ 432 M | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 73.67 | 1.03 % | $ 4.02 B |  Britain |
 |
MiMedx Group
MDXG
|
86.1 M | $ 3.77 | 3.43 % | $ 557 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 11.2 | 3.23 % | $ 401 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.0 | -4.29 % | $ 16.9 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.54 | 14.55 % | $ 62.7 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 37.58 | -2.06 % | $ 318 M | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.9 | 3.7 % | $ 37.7 M | USA |
 |
Butterfly Network
BFLY
|
101 M | $ 4.42 | 7.8 % | $ 1.09 B | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Orthofix Medical
OFIX
|
401 M | $ 12.16 | 0.58 % | $ 482 M |  Curacao |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
6.58 M | $ 2.19 | -0.45 % | $ 6.07 M | USA |
 |
Profound Medical Corp.
PROF
|
11 M | $ 6.95 | 3.19 % | $ 210 M | Canada |
 |
Globus Medical
GMED
|
730 M | $ 83.98 | 5.06 % | $ 11.4 B | USA |
 |
Insulet Corporation
PODD
|
1.68 B | $ 157.2 | 1.68 % | $ 11.1 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 36.7 | 1.44 % | $ 1.14 B | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 44.19 | 3.87 % | $ 1.3 B | USA |
 |
TransMedics Group
TMDX
|
595 M | $ 68.79 | 4.01 % | $ 2.34 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 91.17 | 0.81 % | $ 3.17 B | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 82.96 | 0.97 % | $ 48.5 B | USA |